AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 41c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. CVS
9. SPY
10. XYZ

Go back to AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 41c

AVITA Medical Reports First Quarter Financial Results

May 13, 2024 4:01 PM EDT

VALENCIA, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the first quarter ended March 31, 2024.

Financial Results and Recent Business Updates

Commercial revenue increased approximately 5.8% to $11.1 million compared to the same period in 2023Gross profit margin of 86.4%Launched PermeaDerm, a co-branded biosynthetic wound matrix, in the U.S. on March 23, 2024

We believe we have taken the necessary... More